赛莱乐与降纤酶联合对急性脑梗死患者的效果研究  

Study on the Effect of Serelele Combined with Defibrase on Patients with Acute Cerebral In farction

作　　者：冉倩 RAN Qian(Department of Neurology,Nanyang Central Hospital,Nanyang Henan 473000,China)

机构地区：[1]南阳市中心医院神经内科

出　　处：《药品评价》2019年第19期57-57,63,共2页Drug Evaluation

摘　　要：目的:探讨赛莱乐与降纤酶联合对急性脑梗死患者的效果研究。方法:选取我院收治的急性脑梗死患者90例随机分为两组,对照组应用赛莱乐治疗,研究组赛莱乐与降纤酶联合治疗。结果:研究组治疗效果好于对照组(P<0.05);研究组神经功能缺损小于对照组(P<0.05);研究组血液黏稠度变化好于对照组(P<0.05)。结论:赛莱乐和降纤酶联合运用,对急性的脑梗死症状较安全、其疗效较高,值得加大推广运用。Objective: To investigate the effect of celestine combined with defibrase on patients with acute cerebral infarction. Methods: 90 patients with acute cerebral infarction were randomly divided into two groups. The control group was treated with celestil, and the study group was treated with celestil combined with defibrase. Results: The therapeutic effect in the study group was better than that in the control group(P<0.05). Neurological defects in the study group were smaller than those in the control group(P<0.05). The change of blood viscosity in the study group was better than that in the control group(P<0.05). Conclusion: The combined application of celestil and defibrase is safe and effective for acute cerebral infarction.

关 键 词：赛莱乐 降纤酶 急性脑梗死 

分 类 号：R743.33[医药卫生—神经病学与精神病学]